Lumexa Imaging HoldingsLMRI +14.37%8 ROC (Joel Greenblatt) % is 31.70% as of Mar. 2026, which is 16% above its 10-year median of 27.28. GuruFocus rates LMRI with a GF Score™ of 8/100. The stock has 2 warning signs investors should review. Among 841 Medical Devices & Instruments companies, Lumexa Imaging Holdings ranks better than 56.84% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Lumexa Imaging Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 31.70%.
The historical rank and industry rank for Lumexa Imaging Holdings's ROC (Joel Greenblatt) % or its related term are showing as below:
LMRI'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 9.33 Med: 27.28 Max: 39.72
Current: 9.33
During the past 3 years, Lumexa Imaging Holdings's highest ROC (Joel Greenblatt) % was 39.72%. The lowest was 9.33%. And the median was 27.28%.
LMRI's ROC (Joel Greenblatt) % is ranked better than 56.84% of 841
companies
in the Medical Devices & Instruments industry
Industry Median: 4.13
vs LMRI: 9.33
Lumexa Imaging Holdings's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Lumexa Imaging Holdings ROC (Joel Greenblatt) % Related Terms
Lumexa Imaging Holdings ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Lumexa Imaging Holdings's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LMRI vs SSII, CBLL, AVR: ROC (Joel Greenblatt) % Comparison
For the Medical Devices subindustry, Lumexa Imaging Holdings's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lumexa Imaging Holdings ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lumexa Imaging Holdings's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Lumexa Imaging Holdings's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 31.70% mean?
Lumexa Imaging Holdings (LMRI) has a ROC (Joel Greenblatt) % of 31.70% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Lumexa Imaging Holdings and its competitors. This is 16% above median its historical median of 27.28. Over the past decade, Lumexa Imaging Holdings' ROC (Joel Greenblatt) % has ranged from 9.33 to 39.72. According to the industry distribution chart, Lumexa Imaging Holdings ranks #363 out of 841 companies in the Medical Devices & Instruments industry, placing it in the top 43.2%.
Is Lumexa Imaging Holdings' ROC (Joel Greenblatt) % too high?
Lumexa Imaging Holdings' current ROC (Joel Greenblatt) % of 31.70% is 16% above median its 10-year median of 27.28. Over the past 10 years, this metric has ranged from a low of 9.33 to a high of 39.72. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.13. Lumexa Imaging Holdings' value of 31.70% is 667.6% above this industry median. Based on the distribution chart, Lumexa Imaging Holdings ranks #363 out of 841 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Lumexa Imaging Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Lumexa Imaging Holdings' ROC (Joel Greenblatt) % compare to SSII and CBLL?
According to the Medical Devices & Instruments industry distribution chart, Lumexa Imaging Holdings ranks #363 out of 841 companies for ROC (Joel Greenblatt) %. This puts Lumexa Imaging Holdings in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 4.13. Lumexa Imaging Holdings' value of 31.70% is 667.6% above this benchmark. Historically, Lumexa Imaging Holdings' own ROC (Joel Greenblatt) % has ranged from 9.33 to 39.72 over the past decade. While the company's 10-year median is 27.28 vs. the industry median of 4.13, Lumexa Imaging Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.13, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lumexa Imaging Holdings's current ROC (Joel Greenblatt) % of 31.70% is 667.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Lumexa Imaging Holdings and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lumexa Imaging Holdings's current ROC (Joel Greenblatt) % is 31.70%, which is 16% above median its own 10-year median of 27.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumexa Imaging Holdings stock overvalued right now?
Lumexa Imaging Holdings (LMRI) has a current ROC (Joel Greenblatt) % of 31.70%. The current ROC (Joel Greenblatt) % is 31.70%, which is 16% above median its 10-year median of 27.28 and 667.6% above the Medical Devices & Instruments industry median of 4.13. Lumexa Imaging Holdings' overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Lumexa Imaging Holdings (LMRI), the current ROC (Joel Greenblatt) % is 31.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
8GF Score
Get the complete analysis for LMRI
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMRI has been successfully added to your 